0001144204-13-000256.txt : 20130102 0001144204-13-000256.hdr.sgml : 20130101 20130102201146 ACCESSION NUMBER: 0001144204-13-000256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120517 FILED AS OF DATE: 20130102 DATE AS OF CHANGE: 20130102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Power Sean A CENTRAL INDEX KEY: 0001538845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 13503723 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 v331288_form4.xml OWNERSHIP DOCUMENT X0306 4 2012-05-17 0 0001001316 TG THERAPEUTICS, INC. TGTX 0001538845 Power Sean A 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 0 1 0 0 CFO, Secretary and Treasurer COMMON STOCK 2012-05-17 4 F 0 13526 6.25 D 490874 D COMMON STOCK 2012-12-28 4 A 0 75000 0 A 565874 D Represents shares of common stock surrendered by Mr. Power to the Company to satisfy Mr. Power's tax withholding obligation upon the vesting of 37,500 shares of restricted stock in May 2012. Reflects a grant of restricted shares that will vest according to the following schedule: 50% on January 1, 2015; 25% on the later to occur of: (a) the first date that the issuer achieves a market capitalization target of $100M greater than the market capitalization on the date of grant and (b) March 31, 2015; and 25% on the later to occur of: (a) the first date that the issuer achieves a market capitalization target of $200M greater than the market capitalization on the date of grant and (b) June 30, 2015. /s/ Sean A. Power 2013-01-02